Literature DB >> 2360632

Transit of solids through the human colon: regional quantification in the unprepared bowel.

M Proano1, M Camilleri, S F Phillips, M L Brown, G M Thomforde.   

Abstract

We used a noninvasive method to label the solid phase of contents in the unprepared human colon. 111In-labeled Amberlite pellets (0.5-1.8 mm diam) were placed in a gelatin capsule that was then coated with a pH-sensitive polymer (methacrylate). In vitro, the capsules disintegrated in simulated small bowel contents within 1-2 h; when ingested by healthy subjects, capsules released radiolabel in the distal ileum or proximal colon in 13 of 15 subjects. Transit of 111In-pellets through the unprepared colon could then be quantitated radioscintigraphically. Segmental transit was defined in the ascending (AC), transverse (TC), descending (DC), and rectosigmoid (RS) colon. Radioactivity was also quantitated in stools. At 12 h, radioactivity was most obvious in the AC (59 +/- 11%, mean +/- SE) and the TC (21 +/- 6%); at 24 h, counts were distributed equally between AC, TC, and stools (P greater than 0.05); by 48 h, 56 +/- 11% counts had been excreted, although 30 +/- 10% remained in the TC. At 24 and 48 h, the amount in DC or RS was lower (P less than 0.05) than in the TC or in stools. Emptying of the AC was characterized by an initial lag period, when no counts emptied into the TC, followed by a period of emptying that was approximately linear. Thus this simple approach is able to label contents in the healthy human colon. The ascending and transverse colon appear to be sites of storage of solid residue, whereas the left colon and rectosigmoid function mainly as conduits.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2360632     DOI: 10.1152/ajpgi.1990.258.6.G856

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  61 in total

1.  Regional differences in quinine absorption from the undisturbed human colon assessed using a timed release delivery system.

Authors:  J M Hebden; C G Wilson; R C Spiller; P J Gilchrist; E Blackshaw; M E Frier; A C Perkins
Journal:  Pharm Res       Date:  1999-07       Impact factor: 4.200

2.  Measurement of segmental transit through the gut in man. A novel approach by the biomagnetic method.

Authors:  M Basile; M Neri; A Carriero; S Casciardi; S Comani; C Del Gratta; L Di Donato; S Di Luzio; M A Macri; A Pasquarelli
Journal:  Dig Dis Sci       Date:  1992-10       Impact factor: 3.199

Review 3.  Treating irritable bowel syndrome: overview, perspective and future therapies.

Authors:  Michael Camilleri
Journal:  Br J Pharmacol       Date:  2004-03-22       Impact factor: 8.739

Review 4.  Methods for the assessment of small-bowel and colonic transit.

Authors:  Lawrence A Szarka; Michael Camilleri
Journal:  Semin Nucl Med       Date:  2012-03       Impact factor: 4.446

Review 5.  Measurement of gastrointestinal transit.

Authors:  Henry C Lin; Charlene Prather; Robert S Fisher; James H Meyer; Robert W Summers; Mark Pimentel; Richard W McCallum; Louis M A Akkermans; Vera Loening-Baucke
Journal:  Dig Dis Sci       Date:  2005-06       Impact factor: 3.199

6.  HLA-DQ genotype is associated with accelerated small bowel transit in patients with diarrhea-predominant irritable bowel syndrome.

Authors:  Maria I Vazquez-Roque; Michael Camilleri; Paula Carlson; Sanna McKinzie; Joseph A Murray; Tricia L Brantner; Duane D Burton; Alan R Zinsmeister
Journal:  Eur J Gastroenterol Hepatol       Date:  2011-06       Impact factor: 2.566

7.  Luminal bacteria and proteases together decrease adherence of Entamoeba histolytica trophozoites to Chinese hamster ovary epithelial cells: a novel host defence against an enteric pathogen.

Authors:  E P Variyam
Journal:  Gut       Date:  1996-10       Impact factor: 23.059

8.  Gallium-67 activated charcoal: a new method for preparation of radioactive capsules for colonic transit study.

Authors:  Kai-Yuan Cheng; Shih-Chuan Tsai; Wan-Yu Lin
Journal:  Eur J Nucl Med Mol Imaging       Date:  2003-05-07       Impact factor: 9.236

9.  Pilot study of pathophysiology of constipation among community diabetics.

Authors:  D Maleki; M Camilleri; D D Burton; D M Rath-Harvey; L Oenning; J H Pemberton; P A Low
Journal:  Dig Dis Sci       Date:  1998-11       Impact factor: 3.199

10.  Standard medical therapies do not alter colonic transit time in children with treatment-resistant slow-transit constipation.

Authors:  Melanie C C Clarke; Janet W Chase; Susie Gibb; Anthony G Catto-Smith; John M Hutson; Bridget R Southwell
Journal:  Pediatr Surg Int       Date:  2009-05-16       Impact factor: 1.827

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.